Livemedia Home

Previous Events


Next Events

facebook_icon twitter_icon youtube_icon instagram rss_icon

 Login / Register to Livemedia



Υπενθύμιση κωδικού

A+ | A-
GR | GLOBAL | UK

12/05/2017 Congresses | Video | 6o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών | L.Papavasileiou | 2. Pacemaker need after TAVR. Just a nuisance or something more?

 
950 VIEWS EXPANDCOLLAPSE PRESENTATION

Share

174.861 total
535 live
950 video
80.235 photo
Views:

16:30-18:10 TAVR club II
Πρόεδροι: D.Sionis,G.Makos,A.Ziakas,I.Kanakakis
16:30-16:42 1. The “standardized” TAVR procedure today and areas for further improvements
K.Spargias
16:42-16:54 2. Pacemaker need after TAVR. Just a nuisance or something more?
L.Papavasileiou
16:54-17:06 3. Pacemaker indication: yes, no and the grey-zone
A.Kostopoulou
17:06-17:18 4. Why I want to move to lower risk patients?
J.Velianou
17:18-17:30 5. What bothers me to move to lower risk patients?
D.Iliopoulos
17:30-17:42 6. Antiplatelet/anticoagulation issues after TAVR. Current status
G.Dangas
17:42-17:54 7. My best and worst TAVR case of the year. The single most important lesson learned
G.Katsimagklis
17:54-18:10 Συζήτηση


Webtv: THVgreece WebTV
 
Sort by Date | Views
Watch live and on demand the '6th Conference of  Transcatheter Heart Valve Therapies'.
​
The Diagnostic and Therapeutic Center of Athens Hygeia organizes the '6th Conference of  Transcatheter Heart Valve Therapies' that will take place from 12 to 13 May 2017, at Hilton Hotel in Athens, Greece.

For more information please click here.

Παρακολουθήστε ζωντανά και on demand το '6ο Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών'.

Το Διαγνωστικό Θεραπευτικό Κέντρο Αθηνών ΥΓΕΙΑ διοργανώνει το '6o Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών' στις 12 - 13 Μαΐου 2017 στο ξενοδοχείο Hilton στην Αθήνα.

Για περισσότερες πληροφορίες, πατήστε εδώ.
Webtv: THVgreece WebTV
A.Manginas | 1. The foundation of a new... 1.097
K.Spargias | 2. TAVR: The device evolution... 1.174
K.Toutouzas | 3. TAVR: The constantly changing... 1.001
G.Latsios | 4. What is the reasonable training... 1.095
K.Bellos | 5. What is the reasonable training... 1.020
A.Manolis | 6. Who should be performing... 1.722
I.Iakovou | 7. TAVI live case-in-a-box 1.234
S.Pattakos 965
460
D.Cokkinos 1.131
A.Kartapanis 950
I.Goudevenos 979
Στρατής Παττακός | Καρδιοχειρουργός, Διευθυντής... 1.221
1:24
Στέφανος Φούσας | Σ. Διευθυντής - Ε. Καθηγητής... 860
2:31
C.Mourmouris | 1. MSCT screening. Guidance,... 936
Catherine Avgeropoulou, Cardiologist, Director,... 1.013
1:49
Konstantinos Toutouzas | Associate Professor... 1.253
2:08
G.Latsios | 2. TF access today: vessel,... 906
Gregory Pavlides | MD, PhD, FACC, FESC, Professor... 1.051
2:08
N.Bouboulis | 3. Unanimous verdict: non... 924
V.Tzifos | 4. Concomitant coronary artery... 929
E.Skalidis | 5. The advanced renal failure... 1.039
K.Toutouzas | 6. The procedure was flawless... 1.003
K.Spargias | 7. TAVR live-in-a-box 1.028
C.Avgeropoulou | 1. A “Physiologist’s” view... 1.089
C.Chrysohoou | 2. From clinical practice... 1.046
G.Makos | 4. MR Surgery. When to repair... 1.044
G.Pavlides | 5. Trancatheter MV replacement.... 1.001
K.Spargias | 6. MAC and ViV, ViR 959
K.Spargias | 7. Mitraclip case-in-a-box 1.084
K.Spargias | 1. The “standardized” TAVR... 830
Konstantinos Spargias | Director, Transcatheter... 1.400
1:56
George Dangas | FESC, FACC, Professor of... 1.022
2:10
L.Papavasileiou | 2. Pacemaker need after... 950
A.Kostopoulou | 3. Pacemaker indication:... 1.181
J.Velianou | 4. Why I want to move to lower... 987
V. Andoutsopoulou | 5. What bothers me to... 1.244
G.Dangas | 6. Antiplatelet/anticoagulation... 1.080
C.Arampatzis | 7. My best and worst TAVR... 951
K.Raisakis | 1. My best and worst TAVR case... 1.101
V.Tzifos | 2. My best and worst TAVR case... 1.022
P.Davlouros | 3. My best and worst TAVR... 1.084
M.Ηamilos | 4. My best and worst TAVR case... 796
A.Zacharoulis | 5. My best and worst TAVR... 904
A.Synetos | 6. My best and worst TAVR case... 1.105
K.Papadopoulos | 8. My best and worst TAVR... 1.020
Andreas Synetos | MD, PhD, FESC, Cardiologist,... 1.033
1:24
V.Ninios | 1. MitraClip patient selection-... 1.014
V.Ninios | 1. MitraClip patient selection-... 957
G.Pavlides | 3. Mitral interventions: a... 989
S.Pattakos | 6. Which “operable” DMR patient... 954
V.Ninios | 7. Mitraclip case-in-a-box 841
M.Vavouranakis | 1. How I select my TAVR... 950
K.Spargias | 2. How I select my TAVR device?... 927
D.Nikas | 4. How I select my TAVR device?... 927
D.Nikas | 4. How I select my TAVR device?... 710
Q&A / Comments 913
K. Papadopoulos - K.Spargias | 6. TAVR live-in-a-box 971
A.Gkouziouta | 1. The pathophysiology of... 1.091
I.Ikonomidis | 2. Assessing Tricuspid Regurgitation:... 1.044
P.Sfyridis | 3. The unforgotten valve: what... 911
V.Sachpekidis | 5. The multiple valve disease... 1.024
V.Ninios | 6. Mitraclip in TR 875
M.Chrissoheris | 7. FORMA in TR 973
G.Stavridis | 8. The isolated TR inoperable... 998
Q&A / Comments 986
VIDEO UNDER EDITING - L.Michalis | 1. TAVR:... 1.050
D.Angouras | 2. TAVR device durability.... 1.006
L.Poulimenos | 3. Paradox AVS: implications... 1.140
P.Dardas | 4. TAVR in Bicuspid and ViV 908
I.Iakovou | 5. VARC-2 and MVRC definitions 1.021
G.Bompas | 6. The concept of 4D imaging... 1.017
D.Nikas | 7. My best and worst TAVR case... 814
A.Ziakas | 3. My best and worst TAVR case... 1.078
N.Pilatis | 1. My best and worst TAVR case... 796
G.Karavolias | 4. My best and worst TAVR... 1.003
K.Kalogeras | 5. My best and worst TAVR... 754
D.Tsikaderis | 6. My best and worst TAVR... 1.030
A.Manginas | 7. My best and worst TAVR case... 1.010
P. Kourkoveli | 2. My best and worst TAVR... 989
Christina Chrysohoou, MD, Cardiologist,Heart... 922
49
Irene Mastorakou, Cardiac Radiologist,Director,... 846
123
Lampros Michalis, Professor of Cardiology,University... 1.135
49
James Velianou, MD, FRCPC,Interventional... 1.005
69
Georgios Katsimagklis, InterventionalCardiologist,... 1.247
109
12/05 
08:30 - 11:00
TAVR: The astonishing first decade 

Evaluated
Evaluation
08:30 - 08:50
1. The foundation of a new therapy based on RCTs: The TAVR paradigm

Evaluated
Evaluation

Speaker: A. Manginas

08:50 - 09:10
2. TAVR: The device evolution and the clinical outcomes improvements in the first decade

Evaluated
Evaluation

Speaker: K. Spargias

09:10 - 09:30
3. TAVR: The constantly changing patient eligibility criteria. Past, current and future directions

Evaluated
Evaluation

Speaker: K. Toutouzas

09:30 - 09:50
4. What is the reasonable training path for an IC to TAVR today?

Evaluated
Evaluation

Speaker: G. Latsios

09:50 - 10:10
5. What is the reasonable training path for a CTS to TAVR today?

Evaluated
Evaluation

Speaker: K. Bellos

10:10 - 10:30
6. Who should be performing TAVR today? Do Doctors and Patients interests concur?

Evaluated
Evaluation

Speaker: Ant. Manolis

10:30 - 10:50
7. TAVI live case-in-a-box

Evaluated
Evaluation

Speaker: I. Iakovou

10:50 - 11:00
Συζήτηση

Chairmen: D. Cokkinos, S. Pattakos, S. Foussas, N. Ioannou

11:00 - 11:30
OPENING CEREMONY 

11:00 - 00:00

Evaluated
Evaluation

Speakers: S. Pattakos, D. V. Cokkinos, A. Kartapanis, I. Goudevenos

11:30 - 13:30
TAVR club I 

Evaluated
Evaluation
11:30 - 11:45
1. MSCT screening. Guidance, device selection, and outcomes prediction

Evaluated
Evaluation

Speaker: C. Mourmouris

11:45 - 12:00
2. TF access today: vessel, device and experience related minimum requirements, limits, techniques

Evaluated
Evaluation

Speaker: G. Latsios

12:00 - 12:15
3. Unanimous verdict: non TF patient but requires TAVR. Access selection path

Evaluated
Evaluation

Speaker: N. Bouboulis

12:15 - 12:30
4. Concomitant coronary artery disease: significance and an individualized treatment approach

Evaluated
Evaluation

Speaker: V. Tzifos

12:30 - 12:45
5. The advanced renal failure and the on renal replacement patient. Planning, techniques, device selection, valve durability and other issues

Evaluated
Evaluation

Speaker: E. Skalidis

12:45 - 13:00
6. The procedure was flawless but unfortunately the patient never made it to home. Why and how to avoid this in the future

Evaluated
Evaluation

Speaker: K. Toutouzas

13:00 - 13:20
7. TAVR live-in-a-box

Evaluated
Evaluation

Speaker: K. Spargias

13:20 - 13:30
Συζήτηση

Chairmen: G. Sianos, I. Mastorakou, I. Chlorogiannis, A. Dimas

13:30 - 14:00
Break 

14:00 - 16:00
Mitral club I 

Evaluated
Evaluation
14:00 - 14:15
1. A “Physiologist’s” view of the Mitral valve apparatus anatomy

Evaluated
Evaluation

Speaker: C. Avgeropoulou

14:15 - 14:30
2. From clinical practice to guidelines: the world upside down

Evaluated
Evaluation

Speaker: C. Chrysohoou

14:30 - 14:45
3. Innovation breaking news

Evaluated
Evaluation

Speaker: M. Chrissoheris

14:45 - 15:00
4. MR Surgery. When to repair and when to replace and lessons for transcatheter therapies?

Evaluated
Evaluation

Speaker: G. Makos

15:00 - 15:15
5. Trancatheter MV replacement. How close we really are?

Evaluated
Evaluation

Speaker: G. Pavlides

15:15 - 15:30
6. MAC and ViV, ViR

Evaluated
Evaluation

Speaker: K. Spargias

15:30 - 15:45
7. Mitraclip case-in-a-box

Evaluated
Evaluation

Speaker: K. Spargias

15:45 - 16:00
Συζήτηση

Chairmen: Κ. Aggeli, G. Economopoulos, K. Stratos, N. Kafkas

16:00 - 16:30
Break 

16:30 - 18:10
TAVR club II 

Evaluated
Evaluation
16:30 - 16:42
1. The “standardized” TAVR procedure today and areas for further improvements

Evaluated
Evaluation

Speaker: K. Spargias

16:42 - 16:54
2. Pacemaker need after TAVR. Just a nuisance or something more?

Evaluated
Evaluation

Speaker: L. Papavasileiou

16:54 - 17:06
3. Pacemaker indication: yes, no and the grey-zone

Evaluated
Evaluation

Speaker: A. Kostopoulou

17:06 - 17:18
4. Why I want to move to lower risk patients?

Evaluated
Evaluation

Speaker: J. Velianou

17:18 - 17:30
5. What bothers me to move to lower risk patients?

Evaluated
Evaluation

Speaker: D. Iliopoulos

17:30 - 17:42
6. Antiplatelet/anticoagulation issues after TAVR. Current status

Evaluated
Evaluation

Speaker: G. Dangas

17:42 - 17:54
7. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: G. Katsimagklis

17:54 - 18:10
Συζήτηση

Chairmen: D. Sionis, G. Makos, A. Ziakas, I. Kanakakis

18:10 - 20:00
TAVR club III 

Evaluated
Evaluation
18:10 - 18:22
1. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: K. Raisakis

18:22 - 18:34
2. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: V. Tzifos

18:34 - 18:46
3. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: P. Davlouros

18:46 - 18:58
4. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: M. Ηamilos

18:58 - 19:10
5. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: A. Zacharoulis

19:10 - 19:22
6. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: A. Synetos

19:22 - 19:34
7. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: C. Arampatzis

19:34 - 19:46
8. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: K. Papadopoulos

19:46 - 20:00
Συζήτηση

Chairmen: C. Olympios, K. Triantafillou, A. Pitsis, I. Panteliadis, M. Zairis

13/05 
09:00 - 11:00
Mitral club II 

Evaluated
Evaluation
09:00 - 09:15
1. MitraClip patient selection- what are the limits on good outcomes in FMR

Evaluated
Evaluation

Speaker: V. Ninios

09:15 - 09:30
2. MitraClip patient selection- what are the limits on good outcomes in DMR

Evaluated
Evaluation

Speaker: M. Chrissoheris

09:30 - 09:45
3. Mitral interventions: a new challenge for structural interventionalists. How to learn mitral interventions

Evaluated
Evaluation

Speaker: G. Pavlides

09:45 - 10:00
4. Surgical MV replacement and repair in FMR. State of the art (reality vs. the CTSNET and STICH-iMR trials)

Evaluated
Evaluation

Speaker: P. Ponikowski

10:00 - 10:15
5. Innovation breaking news

Evaluated
Evaluation

Speaker: K. Spargias

10:15 - 10:30
6. Which “operable” DMR patient I will opt for transcatheter therapy and why? Should we Surgeons make the first step this time?

Evaluated
Evaluation

Speaker: S. Pattakos

10:30 - 10:45
7. Mitraclip case-in-a-box

Evaluated
Evaluation

Speaker: K. Spargias

10:45 - 11:00
Συζήτηση

Chairmen: S. Adamopoulos, G. Filippatos, A. Trikas

11:00 - 11:30
Break 

11:30 - 13:30
TAVR club IV 

Evaluated
Evaluation
11:30 - 11:45
1. How I select my TAVR device? CoreValve R

Evaluated
Evaluation

Speaker: M. Vavouranakis

11:45 - 12:00
2. How I select my TAVR device? SAPIEN 3

Evaluated
Evaluation

Speaker: K. Spargias

12:00 - 12:15
3. How I select my TAVR device? Lotus

Evaluated
Evaluation

Speaker: K. Toutouzas

12:15 - 12:30
4. How I select my TAVR device? Portico

Evaluated
Evaluation

Speaker: D. N. Nikas

12:30 - 13:10
5. Expert discussion and consensus TAVR device selection (All)

13:10 - 13:30
6. TAVR live-in-a-box

Evaluated
Evaluation

Speaker: K. Spargias

Chairmen: L. Michalis, M. Vavouranakis, K. Spargias, K. Toutouzas, E. Skalidis, P. Dardas, D. Tsikaderis, A. Pitsis, N. Bouboulis, C. Kotoulas, G. Hahalis, G. Stavridis, D. Angouras, G. Bompotis, G. Karavolias, A. Manginas, D. N. Nikas, P. Davlouros, M. Chrissoheris

13:30 - 14:00
Break 

14:00 - 16:00
Tricuspid club 

Evaluated
Evaluation
14:00 - 14:15
1. The pathophysiology of TR, medical management and when intervening is too late?

Evaluated
Evaluation

Speaker: A. Gkouziouta

14:15 - 14:30
2. Assessing Tricuspid Regurgitation: Quantification and Therapeutic Screening

Evaluated
Evaluation

Speaker: I. Ikonomidis

14:30 - 14:45
3. The unforgotten valve: what Surgeons do?

Evaluated
Evaluation

Speaker: F. Mitropoulos

14:45 - 15:00
4. Innovation breaking news

Evaluated
Evaluation

Speaker: K. Spargias

15:00 - 15:15
5. The multiple valve disease patient with TR. Timing, sequence and expectations of treatment

Evaluated
Evaluation

Speaker: V. Sachpekidis

15:15 - 15:30
6. Mitraclip in TR

Evaluated
Evaluation

Speaker: V. Ninios

15:30 - 15:45
7. FORMA in TR

Evaluated
Evaluation

Speaker: M. Chrissoheris

15:45 - 16:00
8. The isolated TR inoperable patient: the ideal candidate for transcatheter therapy?

Evaluated
Evaluation

Speaker: G. Stavridis

Chairmen: C. Karvounis, A. Spanos, A. Pipilis, N. Georgakopoulos

16:00 - 16:30
Break 

16:30 - 18:10
TAVR club V 

Evaluated
Evaluation
16:30 - 16:42
1. TAVR: From clinical practice to guidelines: the world upside down

Evaluated
Evaluation

Speaker: L. Michalis

16:42 - 16:54
2. TAVR device durability. Should I worry? Implications for my lower risk patients

Evaluated
Evaluation

Speaker: D. Angouras

16:54 - 17:06
3. Paradox AVS: implications in TAVR

Evaluated
Evaluation

Speaker: L. Poulimenos

17:06 - 17:18
4. TAVR in Bicuspid and ViV

Evaluated
Evaluation

Speaker: P. Dardas

17:18 - 17:30
5. VARC-2 and MVRC definitions

Evaluated
Evaluation

Speaker: I. Iakovou

17:30 - 17:42
6. The concept of 4D imaging and 3D printing in TAVR and beyond

Evaluated
Evaluation

Speaker: G. Bompas

17:42 - 17:54
7. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: D. N. Nikas

17:54 - 18:10
Συζήτηση

Chairmen: G. Dangas, M. Argiriou, A. Dagre, D. Nikas

18:10 - 20:00
TAVR club VI 

Evaluated
Evaluation
18:10 - 18:22
1. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: N. Pilatis

18:22 - 18:34
2. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: G. Bompotis

18:34 - 18:46
3. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: A. Ziakas

18:46 - 18:58
4. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: G. Karavolias

18:58 - 19:10
5. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: K. Kalogeras

19:10 - 19:22
6. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: D. Tsikaderis

19:22 - 19:34
7. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: A. Manginas

19:34 - 19:46
8. My best and worst TAVR case of the year. The single most important lesson learned

Evaluated
Evaluation

Speaker: K. Perreas

19:46 - 20:00
Συζήτηση

Chairmen: K. Toutouzas, S. Patsilinakos, J. Velianou, S. Konstantinidis, G. Athanassopoulos